Skip to content

Author

M. Matter

We have 2 of 16 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Aug 2026

Serum HBsAg cannot distinguish cccDNA activity from integrated HBV DNA expression in chronic hepatitis B virus infection.

BACKGROUND & AIMS HBsAg is currently used as the key serum biomarker to define functional cure of chronic hepatitis B (CHB). Declining HBsAg is often interpreted as evidence of cccDNA elimination or durable transcriptional silencing. However, HBsAg can also be produced from transcriptionally active HBV DNA integrated i...

A. Suslov, M. Matter, D. Calabrese et al. · 0 citations
Open access Aug 2026

Hepatocellular carcinoma organoids enable drug discovery and combination therapy across heterogeneous tumors.

A biobank of patient-derived HCC organoids generated from diagnostic biopsies is established, establishing patient-derived organoids as a scalable platform for functional drug discovery and support combination strategies improving response across heterogeneous HCC.

S. Nuciforo, L. Blukacz, Marie-Anne Heusler et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.